Elcu Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Elcu General Information

Description

Operator of a drug development company aimed at the development of new drugs for chronic wounds and skin diseases. The company's focus is on the development of drugs for several skin diseases, including non-healing or chronic wounds such as pressure ulcers and foot ulcers, enabling clinicians and medical professionals to cure chronic wound and skin diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Room No 412 Daejeon Binventure Town
  • 1662 Yuseong-daero Yuseong-gu
  • Daejeon, 34054
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Accounting, Audit and Tax Services (B2B)
Vertical(s)
Corporate Office
  • Room No 412 Daejeon Binventure Town
  • 1662 Yuseong-daero Yuseong-gu
  • Daejeon, 34054
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elcu Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 19-Oct-2020 Completed Out of Business
4. Accelerator/Incubator 01-Jun-2017 Completed Generating Revenue
3. Early Stage VC 01-Jan-2017 Completed Generating Revenue
2. Grant 01-Jul-2016 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Elcu’s complete valuation and funding history, request access »

Elcu Patents

Elcu Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020032744-A1 Catechin compound and use thereof Inactive 10-Aug-2018
WO-2020032752-A1 Catechin compound and use thereof Inactive 10-Aug-2018
WO-2018021683-A1 Antioxidative composition containing uldavioside a compound Inactive 29-Jul-2016
WO-2018012773-A1 Anti-inflammatory composition containing uldavioside a compound Inactive 12-Jul-2016
JP-6741866-B2 Wound healing composition containing a compound of uldaviside a Inactive 12-Jul-2016 A61K36/185
To view Elcu’s complete patent history, request access »

Elcu FAQs

  • When was Elcu founded?

    Elcu was founded in 2016.

  • Where is Elcu headquartered?

    Elcu is headquartered in Daejeon, South Korea.

  • What industry is Elcu in?

    Elcu’s primary industry is Drug Discovery.

  • Is Elcu a private or public company?

    Elcu is a Private company.

  • What is Elcu’s current revenue?

    The current revenue for Elcu is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process